CT20p
CT20p is an anticancer peptide derived from the hydrophobic terminal of BaxC. It exhibits a unique cytotoxic effect independent of the full-length Bax, targeting mitochondria to induce fusion-like aggregation and mitochondrial membrane hyperpolarization. CT20p reduces α5β1 integrin levels, inhibits F-actin polymerization, thus disrupting the cytoskeleton and preventing cell adhesion. CT20p is applicable in breast cancer research.
Product Specifications
Field of Research
Cell Biology
Molecular Weight
2176.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2411-23C-Biotin 100 µL
CD57 (CD57 Antigen, Beta-1,3-glucuronyltransferase 1, B3GAT1, Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1, Glucuronosyltransferase P, GLCATP, GlcAT-P, GlcUATP, GlcUAT-P, HNK1, HNK-1, LEU7, LEU7 Antigen, NK1, NK-1, UDP-GlcUA Glycoprotein beta-1,3-glucuronyltransferase) (Biotin) discontinued
Sign In for Pricing
View Details 
